130 related articles for article (PubMed ID: 35267520)
21. Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy.
Egashira N
Front Pain Res (Lausanne); 2021; 2():804260. PubMed ID: 35295491
[TBL] [Abstract][Full Text] [Related]
22. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment.
Kang L; Tian Y; Xu S; Chen H
J Neurol; 2021 Sep; 268(9):3269-3282. PubMed ID: 32474658
[TBL] [Abstract][Full Text] [Related]
23. Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy.
Cavaletti G; Marmiroli P
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32471028
[TBL] [Abstract][Full Text] [Related]
24. Laser acupuncture attenuates oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: a pilot prospective cohort study.
Hsieh YL; Chou LW; Hong SF; Chang FC; Tseng SW; Huang CC; Yang CH; Yang CC; Chiu WF
Acupunct Med; 2016 Oct; 34(5):398-405. PubMed ID: 27613370
[TBL] [Abstract][Full Text] [Related]
25. Oxaliplatin-induced neuropathy and colo-rectal cancer patient's quality of life: Practical lessons from a prospective cross-sectional, real-world study.
Prutianu I; Alexa-Stratulat T; Cristea EO; Nicolau A; Moisuc DC; Covrig AA; Ivanov K; Croitoru AE; Miron MI; Dinu MI; Ivanov AV; Marinca MV; Radu I; Gafton B
World J Clin Cases; 2022 Apr; 10(10):3101-3112. PubMed ID: 35647128
[TBL] [Abstract][Full Text] [Related]
26. Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).
Pachman DR; Qin R; Seisler D; Smith EM; Kaggal S; Novotny P; Ruddy KJ; Lafky JM; Ta LE; Beutler AS; Wagner-Johnston ND; Staff NP; Grothey A; Dougherty PM; Cavaletti G; Loprinzi CL
Support Care Cancer; 2016 Dec; 24(12):5059-5068. PubMed ID: 27534963
[TBL] [Abstract][Full Text] [Related]
27. The Association between Oxaliplatin-Induced Peripheral Neuropathy, Sociodemographic, and Clinical Characteristics with Falls in Older Adults with Colorectal Cancer.
Hines RB; Schoborg C; Sumner T; Thiesfeldt DL; Zhang S
Am J Epidemiol; 2024 May; ():. PubMed ID: 38751324
[TBL] [Abstract][Full Text] [Related]
28. New diagnostic measures of oxaliplatin-induced peripheral sensory neuropathy.
Szpejewska JE; Yilmaz M; Falkmer UG; Arendt-Nielsen L; Mørch CD
Cancer Treat Res Commun; 2022; 31():100543. PubMed ID: 35255440
[TBL] [Abstract][Full Text] [Related]
29. Minocycline for Symptom Reduction During Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial.
Wang XS; Shi Q; Bhadkamkar NA; Cleeland CS; Garcia-Gonzalez A; Aguilar JR; Heijnen C; Eng C
J Pain Symptom Manage; 2019 Oct; 58(4):662-671. PubMed ID: 31254639
[TBL] [Abstract][Full Text] [Related]
30. Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin.
Tofthagen C; McAllister RD; McMillan SC
Clin J Oncol Nurs; 2011 Apr; 15(2):182-8. PubMed ID: 21444285
[TBL] [Abstract][Full Text] [Related]
31. Electrochemical Skin Conductance as a Marker of Painful Oxaliplatin-Induced Peripheral Neuropathy.
Delmotte JB; Tutakhail A; Abdallah K; Reach P; D'Ussel M; Deplanque G; Beaussier H; Coudoré F
Neurol Res Int; 2018; 2018():1254602. PubMed ID: 30363900
[TBL] [Abstract][Full Text] [Related]
32. Patterns of Patient-Reported Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Survivors.
Teng C; ; Blinman PL; Vardy JL
J Natl Compr Canc Netw; 2022 Dec; 20(12):1308-1315. PubMed ID: 36509075
[TBL] [Abstract][Full Text] [Related]
33. A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy.
Kotaka M; Saito Y; Kato T; Satake H; Makiyama A; Tsuji Y; Shinozaki K; Fujiwara T; Mizushima T; Harihara Y; Nagata N; Kurihara N; Ando M; Kusakawa G; Sakai T; Uchida Y; Takamoto M; Kimoto S; Hyodo I
Cancer Chemother Pharmacol; 2020 Nov; 86(5):607-618. PubMed ID: 32965539
[TBL] [Abstract][Full Text] [Related]
34. Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.
Chen SJ; Chen LH; Yeh YM; Lin CK; Lin PC; Huang HW; Shen MR; Lin BW; Lee JC; Lee CC; Lee YF; Chiang HC; Chang JY
Theranostics; 2021; 11(10):4672-4687. PubMed ID: 33754020
[No Abstract] [Full Text] [Related]
35. Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development.
Yang Y; Zhao B; Gao X; Sun J; Ye J; Li J; Cao P
J Exp Clin Cancer Res; 2021 Oct; 40(1):331. PubMed ID: 34686205
[TBL] [Abstract][Full Text] [Related]
36. Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial.
Balayssac D; Ferrier J; Pereira B; Gillet B; Pétorin C; Vein J; Libert F; Eschalier A; Pezet D
BMJ Open; 2015 Apr; 5(4):e007479. PubMed ID: 25833669
[TBL] [Abstract][Full Text] [Related]
37. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
[TBL] [Abstract][Full Text] [Related]
38. Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy.
Cao Y; Chang Q; Zhang W; Ornatsky O; Hedley D; Chen EX
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1195-1200. PubMed ID: 31520102
[TBL] [Abstract][Full Text] [Related]
39. Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy.
Beijers AJM; Bonhof CS; Mols F; Ophorst J; de Vos-Geelen J; Jacobs EMG; van de Poll-Franse LV; Vreugdenhil G
Ann Oncol; 2020 Jan; 31(1):131-136. PubMed ID: 31912787
[TBL] [Abstract][Full Text] [Related]
40. Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).
Pachman DR; Qin R; Seisler DK; Smith EM; Beutler AS; Ta LE; Lafky JM; Wagner-Johnston ND; Ruddy KJ; Dakhil S; Staff NP; Grothey A; Loprinzi CL
J Clin Oncol; 2015 Oct; 33(30):3416-22. PubMed ID: 26282635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
